Penumbral selection of patients for trials of acute stroke therapy

The Lancet Neurology

Volumn 8, Issue 3, 2009, Pages 261-269

  Donnan, Geoffrey A ^a   Baron, Jean Claude ^b   Ma, Henry ^a   Davis, Stephen M ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; CITICOLINE; DESMOTEPLASE; GAVESTINEL; GLYCINE RECEPTOR ANTAGONIST; PLACEBO;

ACUTE DISEASE; BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; BRAIN INFARCTION SIZE; CEREBROVASCULAR ACCIDENT; CHRONOTHERAPY; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DIFFUSION WEIGHTED IMAGING; DISEASE DURATION; DOSE RESPONSE; DRUG DOSE ESCALATION; DRUG EFFECT; DRUG WITHDRAWAL; HUMAN; HYPOTHERMIA; IMAGE ANALYSIS; NEUROPROTECTION; NUCLEAR MAGNETIC RESONANCE IMAGING; OXYGEN THERAPY; PATIENT SELECTION; PERFUSION WEIGHTED IMAGING; PRIORITY JOURNAL; REVIEW; SALVAGE THERAPY; TREATMENT DURATION; TREATMENT RESPONSE;

CLINICAL TRIALS AS TOPIC; FIBRINOLYTIC AGENTS; HUMANS; MAGNETIC RESONANCE IMAGING; PATIENT SELECTION; PLASMINOGEN ACTIVATORS; STROKE; TIME FACTORS; TISSUE PLASMINOGEN ACTIVATOR; TOMOGRAPHY, X-RAY COMPUTED;

EID: 60049091968     PISSN: 14744422     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1474-4422(09)70041-9     Document Type: Review

References (76)

1. Donnan G.A., Fisher M., Macleod M., and Davis S.M. Stroke. Lancet 371 (2008) 1612-1623
2. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med 333 (1995) 1581-1587
3. Hacke W., Donnan G., Fieschi C., et al. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet 363 (2004) 768-774
4. Kleindorfer D., Lindsell C.J., Brass L., Koroshetz W., and Broderick J.P. National US estimates of recombinant tissue plasminogen activator use: ICD-9 codes substantially underestimate. Stroke 39 (2008) 924-928
5. Nadeau J.O., Shi S., Fang J., et al. TPA use for stroke in the Registry of the Canadian Stroke Network. Can J Neurol Sci 32 (2005) 433-439
6. Gilligan A.K., Thrift A.G., Sturm J.W., Dewey H.M., Macdonell R.A., and Donnan G.A. Stroke units, tissue plasminogen activator, aspirin and neuroprotection: which stroke intervention could provide the greatest community benefit?. Cerebrovasc Dis 20 (2005) 239-244
7. Hacke W., Kaste M., Bluhmki E., et al. Thrombolysis with alteplase 3 to 4·5 hours after acute ischemic stroke. N Engl J Med 359 (2008) 1317-1329
8. Whiteley W., Lindley R., Wardlaw J., and Sandercock P. Third International Stroke Trial. Int J Stroke 1 (2006) 172-176
9. Astrup J., Siesjo B.K., and Symon L. Thresholds in cerebral ischemia-the ischemic penumbra. Stroke 12 (1981) 723-725
10. Donnan G.A., Baron J.C., Davis S.M., and Sharp F.R. The Ischemic Penumbra (2007), Informa Healthcare, New York
11. Astrup J., Symon L., Branston N.M., and Lassen N.A. Cortical evoked potential and extracellular K+ and H+ at critical levels of brain ischemia. Stroke 8 (1977) 51-57
12. Baron J. Mapping the ischaemic penumbra with PET: implications for acute stroke treatment. Cerebrovasc Dis 9 (1999) 193-201
13. Read S.J., Hirano T., Abbott D.F., et al. The fate of hypoxic tissue on 18F-fluoromisonidazole positron emission tomography after ischemic stroke. Ann Neurol 48 (2000) 228-235
14. Heiss W.D., Kracht L.W., Thiel A., Grond M., and Pawlik G. Penumbral probability thresholds of cortical flumazenil binding and blood flow predicting tissue outcome in patients with cerebral ischaemia. Brain 124 (2001) 20-29
15. Baird A.E., and Warach S. Magnetic resonance imaging of acute stroke. J Cereb Blood Flow Metab 18 (1998) 583-609
16. Wintermark M., Reichhart M., Thiran J.P., et al. Prognostic accuracy of cerebral blood flow measurement by perfusion computed tomography, at the time of emergency room admission, in acute stroke patients. Ann Neurol 51 (2002) 417-432
17. Davalos A., Pedraz S., and Castillo J. The clinical-DWI mismatch: a new diagnostic clue in the treatment of acute ischemic stroke. Stroke 34 (2003) 254
18. Prosser J., Butcher K., Allport L., et al. Clinical-diffusion mismatch predicts the putative penumbra with high specificity. Stroke 36 (2005) 1700-1704
19. UK Department of Health Stroke Policy Team. Implementing the National Stroke Strategy-an imaging guide (2008), UK Department of Health 1-34
20. Culebras A., Kase C.S., Masdeu J.C., et al. Practice guidelines for the use of imaging in transient ischemic attacks and acute stroke. A report of the Stroke Council, American Heart Association. Stroke 28 (1997) 1480-1497
21. The European Stroke Organization (ESO) Executive Committee and the ESO Writing Committee. Guidelines for Management of Ischaemic Stroke and Transient Ischaemic Attack 2008. In: ESO (Ed). Recommendations for Stroke Management (2008), European Stroke Organization (ESO) 1-120
22. Baird A.E., Lovblad K.O., Schlaug G., Edelman R.R., and Warach S. Multiple acute stroke syndrome: marker of embolic disease?. Neurology 54 (2000) 674-678
23. Chalela J.A., Kidwell C.S., Nentwich L.M., et al. Magnetic resonance imaging and computed tomography in emergency assessment of patients with suspected acute stroke: a prospective comparison. Lancet 369 (2007) 293-298
24. Rother J., Schellinger P.D., Gass A., et al. Effect of intravenous thrombolysis on MRI parameters and functional outcome in acute stroke <6 hours. Stroke 33 (2002) 2438-2445
25. Schellinger P.D., Fiebach J.B., Jansen O., et al. Stroke magnetic resonance imaging within 6 hours after onset of hyperacute cerebral ischemia. Ann Neurol 49 (2001) 460-469
26. Donnan G.A., and Davis S.M. Neuroimaging, the ischaemic penumbra, and selection of patients for acute stroke therapy. Lancet Neurol 1 (2002) 417-425
27. Davis S.M., Donnan G.A., Butcher K.S., and Parsons M. Selection of thrombolytic therapy beyond 3 h using magnetic resonance imaging. Curr Opin Neurol 18 (2005) 47-52
28. Muir K.W., Buchan A., von Kummer R., Rother J., and Baron J.C. Imaging of acute stroke. Lancet Neurol 5 (2006) 755-768
29. Kidwell C.S., Alger J.R., and Saver J.L. Beyond mismatch: evolving paradigms in imaging the ischemic penumbra with multimodal magnetic resonance imaging. Stroke 34 (2003) 2729-2735
30. Kidwell C.S., Saver J.L., Mattiello J., et al. Thrombolytic reversal of acute human cerebral ischemic injury shown by diffusion/perfusion magnetic resonance imaging. Ann Neurol 47 (2000) 462-469
31. Rother J., de Crespigny A.J., D'Arceuil H., Iwai K., and Moseley M.E. Recovery of apparent diffusion coefficient after ischemia-induced spreading depression relates to cerebral perfusion gradient. Stroke 27 (1996) 980-986
32. Fiehler J., Knudsen K., Kucinski T., et al. Predictors of apparent diffusion coefficient normalization in stroke patients. Stroke 35 (2004) 514-519
33. Guadagno J.V., Warburton E.A., Jones P.S., et al. How affected is oxygen metabolism in DWI lesions? A combined acute stroke PET-MR study. Neurology 67 (2006) 824-829
34. Baird A.E., Benfield A., Schlaug G., et al. Enlargement of human cerebral ischemic lesion volumes measured by diffusion-weighted magnetic resonance imaging. Ann Neurol 41 (1997) 581-589
35. Barber P.A., Darby D.G., Desmond P.M., et al. Prediction of stroke outcome with echoplanar perfusion- and diffusion-weighted MRI. Neurology 51 (1998) 418-426
36. Baird T.A., Parsons M.W., Phanh T., et al. Persistent poststroke hyperglycemia is independently associated with infarct expansion and worse clinical outcome. Stroke 34 (2003) 2208-2214
37. Allport L.E., Parsons M.W., Butcher K.S., et al. Elevated hematocrit is associated with reduced reperfusion and tissue survival in acute stroke. Neurology 65 (2005) 1382-1387
38. Ay H., Koroshetz W.J., Vangel M., et al. Conversion of ischemic brain tissue into infarction increases with age. Stroke 36 (2005) 2632-2636
39. Singhal A.B., Benner T., Roccatagliata L., et al. A pilot study of normobaric oxygen therapy in acute ischemic stroke. Stroke 36 (2005) 797-802
40. King-Im J.U., Trivedi R.A., Graves M.J., et al. Utility of an ultrafast magnetic resonance imaging protocol in recent and semi-recent strokes. J Neurol Neurosurg Psychiatry 76 (2005) 1002-1005
41. Kidwell C.S., Chalela J.A., Saver J.L., et al. Comparison of MRI and CT for detection of acute intracerebral hemorrhage. JAMA 292 (2004) 1823-1830
42. Ostergaard L., Weisskoff R.M., Chesler D.A., Gyldensted C., and Rosen B.R. High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part I: mathematical approach and statistical analysis. Magn Reson Med 36 (1996) 715-725
43. Petersen E.T., Zimine I., Ho Y.C., and Golay X. Non-invasive measurement of perfusion: a critical review of arterial spin labelling techniques. Br J Radiol 79 (2006) 688-701
44. Wu O., Ostergaard L., Weisskoff R.M., Benner T., Rosen B.R., and Sorensen A.G. Tracer arrival timing-insensitive technique for estimating flow in MR perfusion-weighted imaging using singular value decomposition with a block-circulant deconvolution matrix. Magn Reson Med 50 (2003) 164-174
45. Hjort N., Butcher K., Davis S.M., et al. Magnetic resonance imaging criteria for thrombolysis in acute cerebral infarct. Stroke 36 (2005) 388-397
46. Neumann-Haefelin T., Wittsack H.J., Wenserski F., et al. Diffusion- and perfusion-weighted MRI. The DWI/PWI mismatch region in acute stroke. Stroke 30 (1999) 1591-1597
47. Ostergaard L. Principles of cerebral perfusion imaging by bolus tracking. J Magn Res Imag 22 (2005) 710-717
48. Shih L.C., Saver J.L., Alger J.R., et al. Perfusion-weighted magnetic resonance imaging thresholds identifying core, irreversibly infarcted tissue. Stroke 34 (2003) 1425-1430
49. Knutsson L., Bloch K.M., Holtas S., Wirestam R., and Stahlberg F. Model-free arterial spin labelling for cerebral blood flow quantification: introduction of regional arterial input functions identified by factor analysis. Magn Reson Imaging 26 (2008) 554-559
50. Macintosh B.J., Pattinson K.T., Gallichan D., et al. Measuring the effects of remifentanil on cerebral blood flow and arterial arrival time using 3D GRASE MRI with pulsed arterial spin labelling. J Cereb Blood Flow Metab 28 (2008) 1514-1522
51. Noth U., Kotajima F., Deichmann R., Turner R., and Corfield D.R. Mapping of the cerebral vascular response to hypoxia and hypercapnia using quantitative perfusion MRI at 3 T. NMR Biomed 21 (2008) 464-472
52. Wintermark M., Reichhart M., Cuisenaire O., et al. Comparison of admission perfusion computed tomography and qualitative diffusion- and perfusion-weighted magnetic resonance imaging in acute stroke patients. Stroke 33 (2002) 2025-2031
53. Parsons M.W., Pepper E.M., Chan V., et al. Perfusion computed tomography: prediction of final infarct extent and stroke outcome. Ann Neurol 58 (2005) 672-679
54. Hellier K.D., Hampton J.L., Guadagno J.V., et al. Perfusion CT helps decision making for thrombolysis when there is no clear time of onset. J Neurol Neurosurg Psychiatry 77 (2006) 417-419
55. Wintermark M., Meuli R., Browaeys P., et al. Comparison of CT perfusion and angiography and MRI in selecting stroke patients for acute treatment. Neurology 68 (2007) 694-697
56. Kloska S.P., Fischer T., Nabavi D.G., et al. Color-coded perfused blood volume imaging using multidetector CT: initial results of whole-brain perfusion analysis in acute cerebral ischemia. Eur Radiol 17 (2007) 2352-2358
57. Dittrich R., Akdeniz S., Kloska S.P., et al. Low rate of contrast-induced Nephropathy after CT perfusion and CT angiography in acute stroke patients. J Neurol 254 (2007) 1491-1497
58. Thomsen H.S., Marckmann P., and Logager V.B. Enhanced computed tomography or magnetic resonance imaging: a choice between contrast medium-induced nephropathy and nephrogenic systemic fibrosis?. Acta Radiol 48 (2007) 593-596
59. Davis S.M., Donnan G.A., Parsons M.W., et al. Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial. Lancet Neurol 7 (2008) 299-309
60. Albers G.W., Thijs V.N., Wechsler L., et al. Magnetic resonance imaging profiles predict clinical response to early reperfusion: the diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study. Ann Neurol 60 (2006) 508-517
61. Hacke W., Albers G., Al-Rawi Y., et al. The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase. Stroke 36 (2005) 66-73
62. Furlan A.J., Eyding D., Albers G.W., et al. Dose Escalation of Desmoteplase for Acute Ischemic Stroke (DEDAS): evidence of safety and efficacy 3 to 9 hours after stroke onset. Stroke 37 (2006) 1227-1231
63. Hacke W., Furlan A.J., Al-Rawi Y., et al. Intravenous desmoteplase in patients with acute ischaemic stroke selected by MRI perfusion-diffusion weighted imaging or perfusion CT (DIAS-2): a prospective, randomised, double-blind, placebo-controlled study. Lancet Neurol 8 (2008) 141-150
64. Singer O.C., Humpich M.C., Fiehler J., et al. Risk for symptomatic intracerebral hemorrhage after thrombolysis assessed by diffusion-weighted magnetic resonance imaging. Ann Neurol 63 (2008) 52-60
65. Chow S.-C., Shao J., and Wang H. Sample Size Calculations in Clinical Research. 2nd edn. (2008), Chapman and Hall/CRC, Florida
66. Dupont W.D., and Plummer W.D. PS power and sample size program available for free on the internet. Contr Clin Trials 18 (1997) 274
67. Warach S., Kaufman D., Chiu D., et al. Effect of the Glycine Antagonist Gavestinel on cerebral infarcts in acute stroke patients, a randomized placebo-controlled trial: the GAIN MRI substudy. Cerebrovasc Dis 21 (2006) 106-111
68. Warach S., Pettigrew L.C., Dashe J.F., et al. Effect of citicoline on ischemic lesions as measured by diffusion-weighted magnetic resonance imaging. Citicoline 010 Investigators. Ann Neurol 48 (2000) 713-722
69. De Georgia M.A., Krieger D.W., Abou-Chebl A., et al. Cooling for Acute Ischemic Brain Damage (COOL AID): a feasibility trial of endovascular cooling. Neurology 63 (2004) 312-317
70. Acute Stroke Imaging Standardization Group. ASIST-Japan. http://asist.umin.jp/index-e.htm (accessed 28 Jan, 2009).
71. Sobesky J., Zaro Weber O., Lehnhardt F.G., et al. Does the mismatch match the penumbra? Magnetic resonance imaging and positron emission tomography in early ischemic stroke. Stroke 36 (2005) 980-985
72. Takasawa M., Jones P.S., Guadagno J.V., et al. How reliable is perfusion MR in acute stroke? Validation and determination of the penumbra threshold against quantitative PET. Stroke 39 (2008) 870-877
73. Calamante F., Yim P.J., and Cebral J.R. Estimation of bolus dispersion effects in perfusion MRI using image-based computational fluid dynamics. Neuroimage 19 (2003) 341-353
74. Calamante F., Willats L., Gadian D.G., and Connelly A. Bolus delay and dispersion in perfusion MRI: implications for tissue predictor models in stroke. Magn Reson Med 55 (2006) 1180-1185
75. Furlan A., Higashida R., Wechsler L., et al. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA 282 (1999) 2003-2011
76. Barber P.A., Davis S.M., Darby D.G., et al. Absent middle cerebral artery flow predicts the presence and evolution of the ischemic penumbra. Neurology 52 (1999) 1125-1132